0001981285-25-000005.txt : 20251212 0001981285-25-000005.hdr.sgml : 20251212 20251212133324 ACCESSION NUMBER: 0001981285-25-000005 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251212 DATE AS OF CHANGE: 20251212 EFFECTIVENESS DATE: 20251212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Consano Bio, Inc. CENTRAL INDEX KEY: 0001981285 ORGANIZATION NAME: EIN: 920833225 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-566664 FILM NUMBER: 251567455 BUSINESS ADDRESS: STREET 1: 100 SUMMIT DRIVE CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 617-798-4559 MAIL ADDRESS: STREET 1: 100 SUMMIT DRIVE CITY: BURLINGTON STATE: MA ZIP: 01803 FORMER COMPANY: FORMER CONFORMED NAME: CONSANO BIOLOGICS, LLC DATE OF NAME CHANGE: 20230613 D 1 primary_doc.xml X0708 D LIVE 0001981285 Consano Bio, Inc. 100 SUMMIT DRIVE BURLINGTON MA MASSACHUSETTS 01803 617-798-4559 DELAWARE CONSANO BIOLOGICS, LLC Corporation true 2022 Andrew Hall 100 Summit Drive Burlington MA MASSACHUSETTS 01803 Executive Officer Director Chief Executive Officer and Secretary of Issuer Jennifer Schmitke 100 Summit Drive Burlington MA MASSACHUSETTS 01803 Executive Officer President and Chief Operating Officer of Issuer Doug Vander Weide 100 Summit Drive Burlington MA MASSACHUSETTS 01803 Director Chris Centeno 100 Summit Drive Burlington MA MASSACHUSETTS 01803 Director Bill Abbington 100 Summit Drive Burlington MA MASSACHUSETTS 01803 Director Jerome Adams 100 Summit Drive Burlington MA MASSACHUSETTS 01803 Director Biotechnology Decline to Disclose 06b false 2024-10-15 true true true false 0 16840000 16840000 0 false 18 0 0 0 false Consano Bio, Inc. /s/Andrew Hall Andrew Hall Chief Executive Officer of Issuer 2025-12-12